过去一年中添加的文章，按日期排序
Discovery of potential 1, 2, 4-triazole derivatives as aromatase inhibitors for breast cancer: pharmacophore modelling, virtual screening, docking, ADMET and MD …
C Pathak, BW Matore, J Singh, PP Roy… - Molecular …, 2024 - Taylor & Francis
2 天前 - … Hormone receptor (HR)-positive breast cancer, a subtype characterised by the
presence of receptor … hormone-dependent breast cancers by promoting the proliferation of breast …
presence of receptor … hormone-dependent breast cancers by promoting the proliferation of breast …
Optimizing transcriptome-based synthetic lethality predictions to improve precision oncology in early-stage breast cancer: BC-SELECT
Y Kim, M Nagy, B Pollard, PS Rajagopal - bioRxiv, 2024 - biorxiv.org
2 天前 - … in the example of PARP inhibitors as used to treating cancers with a BRCA1/2 …
breadth of these tools across numerous cancer types as published, their translational …
breadth of these tools across numerous cancer types as published, their translational …
In vitro prediction of response to hCG therapy in patients with cryptorchidism and testicular torsion in a gubernaculum-based model
A Errico - 2024 - iris.univr.it
2 天前 - … but also for testicular cancer development is represented … receptor, ie follicle
stimulating hormone receptor (FSHR), … treatment scheme in order to mimic as much as possible …
stimulating hormone receptor (FSHR), … treatment scheme in order to mimic as much as possible …
… : Capivasertib With Fulvestrant for Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Locally Advanced or Metastatic Breast Cancer …
A Dilawari, J Buturla, C Osgood, X Gao… - Journal of Clinical …, 2024 - ascopubs.org
4 天前 - PURPOSE The US Food and Drug Administration (FDA) approved capivasertib in
combination with fulvestrant for adult patients with hormone receptor–positive, human …
combination with fulvestrant for adult patients with hormone receptor–positive, human …
Isolation of Potent 5α-Reductase Inhibitors and Antioxidants from Sphaeranthus indicus Linn. for the Management of Benign Prostatic Hyperplasia
BL Abhirami, AA Krishna, MB Bashi, BS Abhijith… - Plant Foods for Human …, 2024 - Springer
4 天前 - … The plant kingdom encompasses roughly 250,000 species, but only about 10%
of them have been investigated for their therapeutic potential in treating different diseases. …
of them have been investigated for their therapeutic potential in treating different diseases. …
[HTML][HTML] Role of inflammation and immune response in the pathogenesis of uterine fibroids: including their negative impact on reproductive outcomes
H Ishikawa, Y Goto, C Hirooka, E Katayama… - Journal of Reproductive …, 2024 - Elsevier
8 天前 - … Uterine fibroids (UFs), the most common tumors in women of reproductive age,
are … Furthermore, we summarized possible mechanisms of the negative impact of UFs on …
are … Furthermore, we summarized possible mechanisms of the negative impact of UFs on …
[PDF][PDF] Prediction, Prevention, Prognostic and Personalized Therapy of Ovarian Cancer-Biomarkers and Precision Medicine
X Huang, J Lu, Y Zhang, J Qiu, G Yao… - Journal of Cancer …, 2024 - fortunepublish.com
9 天前 - … , hormone receptors, and immune factors. Early detection is now possible thanks
to some effective screening strategies. The ovarian cancer is divided into different clinical …
to some effective screening strategies. The ovarian cancer is divided into different clinical …
[PDF][PDF] Triple Negative Evaluation of FFPE (Formalin Fixed Embedded Tissue) Breast Cancer Tissues in A Tertiary Health Institution of Bayelsa State, Nigeria
II Godwin, CPP Tobias, OI Samuel, CJ Nkechi… - Saudi J …, 2024 - saudijournals.com
11 天前 - … treatment and outcomes to provide individualized care. Some biomarker advancements,
such as hormone receptors, … It is also possible that the molecular phenotypes of African …
such as hormone receptors, … It is also possible that the molecular phenotypes of African …
New potential selective estrogen receptor modulators in traditional Chinese medicine for treating menopausal syndrome
X Song, L Shen, JM Contreras, Z Liu, K Ma… - Phytotherapy … - Wiley Online Library
14 天前 - … breast cancer by 56% after 4 years of treatment and has been approved by the
FDA to pair with estrogen for treating hot flashes and bone loss in women undergoing PS. …
FDA to pair with estrogen for treating hot flashes and bone loss in women undergoing PS. …
Systemic Treatments for Metastatic Prostate Cancer in 2024
14 天前 - … treatments are still largely unknown. This review summarizes the different systemic
therapeutic … for metastatic PCa and discusses a potential algorithm for treatment selection. …
therapeutic … for metastatic PCa and discusses a potential algorithm for treatment selection. …